Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Remodeling of the Neurovascular Unit Following Cerebral Ischemia and Hemorrhage. | Cells | 2022 | 36139398 | PubTator, text mining | PubMed |
| Pulmonary Vascular Sequelae of Palliated Single Ventricle Circulation: Arteriovenous Malformations and Aortopulmonary Collaterals. | J Cardiovasc Dev Dis | 2022 | 36135454 | PubTator, text mining | PubMed |
| Role of Molecular Targeted Therapeutic Drugs in Treatment of Oral Squamous Cell Carcinoma: Development and Current Strategies-A Review Article. | Glob Med Genet | 2022 | 36132998 | PubTator, text mining | PubMed |
| A challenging case of anemia, respiratory failure and seizures. | Acta Biomed | 2022 | 36129446 | PubTator, text mining | PubMed |
| Editorial: TGF-β and BMP signaling in cancer. | Front Cell Dev Biol | 2022 | 36120575 | PubTator, text mining | PubMed |
| Liver Transplantation for Extra-Hepatic Manifestation of Hereditary Hemorrhagic Telangiectasia. | Cureus | 2022 | 36120248 | PubTator, text mining | PubMed |
| TGF-β signaling in the tumor metabolic microenvironment and targeted therapies. | J Hematol Oncol | 2022 | 36115986 | PubTator, text mining | PubMed |
| BMP and activin membrane-bound inhibitor regulate connective tissue growth factor controlling mesothelioma cell proliferation. | BMC Cancer | 2022 | 36109807 | PubTator, text mining | PubMed |
| Case Report: Clinical characteristics and genetic analysis of two patients with hereditary hemorrhagic telangiectasia. | Front Genet | 2022 | 36092899 | PubTator, text mining | PubMed |
| Metformin suppresses proliferation and differentiation induced by BMP9 via AMPK signaling in human fetal lung fibroblast-1. | Front Pharmacol | 2022 | 36091775 | PubTator, text mining | PubMed |
Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study. | Pathologica | 2022 | 36083243 | PubTator, text mining | PubMed |
| Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management. | J Clin Med | 2022 | 36079173 | PubTator, text mining | PubMed |
| Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling. | Cancers (Basel) | 2022 | 36077653 | PubTator, text mining | PubMed |
| The Role of Insulin Receptor Substrate Proteins in Bronchopulmonary Dysplasia and Asthma: New Potential Perspectives. | Int J Mol Sci | 2022 | 36077511 | PubTator, text mining | PubMed |
| Molecular Pathways in Pulmonary Arterial Hypertension. | Int J Mol Sci | 2022 | 36077398 | PubTator, text mining | PubMed |
| An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases. | Int J Mol Sci | 2022 | 36077185 | PubTator, text mining | PubMed |
| Dominant effects of the histone mutant H3-L61R on Spt16-gene interactions in budding yeast. | Epigenetics | 2022 | 36073733 | PubTator, text mining | PubMed |
| Liver involvement in a hereditary hemorrhagic telangiectasia patient with Gd-EOB-DTPA enhanced MRI: a case description. | Quant Imaging Med Surg | 2022 | 36060585 | PubTator, text mining | PubMed |
| Endoglin and Systemic Sclerosis: A PRISMA-driven systematic review. | Front Med (Lausanne) | 2022 | 36059817 | PubTator, text mining | PubMed |
| AI protein structure prediction-based modeling and mutagenesis of a protostome receptor and peptide ligands reveal key residues for their interaction. | J Biol Chem | 2022 | 36049520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=34